Skip to content

Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting

Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02306356
Enrollment
20
Registered
2014-12-03
Start date
2014-09-30
Completion date
2015-10-31
Last updated
2016-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety Disorder, Separation Anxiety, Specific Phobia

Brief summary

An open trial will be conducted at the Child and Mental Health Service (CAMHS) unit in the rural county Jämtland in Sweden to test the feasibility and efficacy of Internet-delivered Cognitive Behavior Therapy (ICBT) for children with anxiety disorders in a clinical setting. 20 children with a principal diagnosis of Generalized Anxiety Disorder (GAD), separation anxiety, specific phobia and their parents will be recruited from the CAMHS-center in Östersund. They will receive 12 weeks of therapist-supported ICBT and will be assessed by clinician ratings and child- and parent-reports at baseline, post-treatment and 3 month follow-up. The primary outcome measures the Clinical Global Impressions - Severity scale (CGI-S). Secondary outcome measures include clinician rated global functioning, and child and parent-rated anxiety and functioning.

Interventions

Sponsors

BUP Östersund
CollaboratorUNKNOWN
Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* 8-12 years of age * Fulfilling diagnostic criteria for Generalized Anxiety Disorder (GAD), Separation anxiety, Specific phobia * Ability to read and write Swedish * Daily access to the internet * A parent that is able to co-participate in the treatment * Participants on psychotropic medication must have been on a stable dose for the last 3 months prior to baseline assessment

Exclusion criteria

* Diagnosed autism spectrum disorder or Attention-deficit/hyperactivity disorder (ADHD), or principal primary disorder other than GAD, Separation anxiety, Specific phobia * Acute/severe psychiatric problems such as suicidal risk or severe depression * Ongoing psychological treatment for anxiety disorders * Ongoing child custody dispute or abuse in the family

Design outcomes

Primary

MeasureTime frameDescription
Change in Clinical Global Impressions - severity (CGI-S)baseline, post-treatment (12 weeks), follow-up (3 months)Change in CGI-s from baseline to post-treatment and follow-up

Secondary

MeasureTime frame
Spence Child Anxiety Scale C/P (SCAS-C/P)Baseline, post-treatment (12 weeks), follow-up (3 months)
Penn State Worry Questionnaire (PSWQ)Baseline, post-treatment (12 weeks), follow-up (3 months)
Separation Anxiety Index (SAI)Baseline, post-treatment (12 weeks), follow-up (3 months)
Fear Survey Schedule for Children - Revised (FSSC-R)Baseline, post-treatment (12 weeks), follow-up (3 months)
Children´s Global Assessment Scale (CGASBaseline, post-treatment (12 weeks), follow-up (3 months)
Child Depression Inventory (CDI)Baseline, post-treatment (12 weeks), follow-up (3 months)
Hospital Anxiety Depression Scale (HAD)Baseline, post-treatment (12 weeks), follow-up (3 months)
Client Satisfaction Scale (CSS)post-treatment (12 weeks)
Trimbos and Institute of Technology Cost Questionnaire for Psychiatry (TIC-P)Baseline, post-treatment (12 weeks), follow-up (3 months)
Child Sheehan Disability Scale (CSDS)Baseline, post-treatment (12 weeks), follow-up (3 months)

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026